We first performed a case-control study of the prominent MS risk allele HLA-DRB1*15:01 in African Americans to determine whether there were any differences in risk conferred by HLA-DRB1*15:01 alleles of European and African origin. The gene discussed is HLA-DRB1; the disease is myeloid sarcoma.